Amit Oza
MD
Medical Oncologist
👥Biography 个人简介
Amit Oza at Princess Margaret is a veteran ovarian cancer investigator who led development of rucaparib and the ARIEL series of trials that contributed to its approval in BRCA-mutated ovarian cancer. His contributions to understanding PARP inhibitor activity, resistance mechanisms, and combination strategies have shaped the therapeutic landscape for relapsed ovarian cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Amit Oza 的研究动态
Follow Amit Oza's research updates
留下邮箱，当我们发布与 Amit Oza（Princess Margaret Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment